Be part of the knowledge.™

Gastroenterology and Hepatology

174

LikeLikedUnlike

1-15 of 93

Playing the Long Game: Improving Durable Control in IBD
CME/CE
Playing the Long Game: Improving Durable Control in IBD
- Anita Afzali, MD, MPH, MHCM, FACG, AGAF
1.00 credits
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
CME/CE
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
0.50 credits
MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
- David T. Rubin, MD
- Michael Dolinger, MD, MBA
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 credits 13 episodes
Setting the Stage: Why Rethinking IBD Care Matters Now
MinuteCE®
Setting the Stage: Why Rethinking IBD Care Matters Now
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
2.00 program credits
Defining Success in IBD: Treat-to-Target
MinuteCE®
Defining Success in IBD: Treat-to-Target
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 program credits
Where Conventional IBD Therapies Fall Short
MinuteCE®
Where Conventional IBD Therapies Fall Short
- Ugo Iroku, MD, MHS
- Michael Dolinger, MD, MBA
2.00 program credits
advertisement
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
MinuteCE®
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
- Michael Dolinger, MD, MBA
- Florence Odufalu, MD
2.00 program credits
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
MinuteCE®
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
MinuteCE®
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
MinuteCE®
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
The Future of Biologic Treatment in IBD: What’s on the Horizon
MinuteCE®
The Future of Biologic Treatment in IBD: What’s on the Horizon
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
MinuteCE®
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
- Florence Odufalu, MD
- David T. Rubin, MD
2.00 program credits
advertisement
The Evolving Role of Small Molecules in IBD Care
MinuteCE®
The Evolving Role of Small Molecules in IBD Care
- Florence Odufalu, MD
- David T. Rubin, MD
2.00 program credits
Putting It All Together: A Practical IBD Treatment Selection Primer
MinuteCE®
Putting It All Together: A Practical IBD Treatment Selection Primer
- Ugo Iroku, MD, MHS
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Navigating IBD Guidelines: What Clinicians Need to Know Now
MinuteCE®
Navigating IBD Guidelines: What Clinicians Need to Know Now
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended